Literature DB >> 30576064

Ginsenoside Rd Inhibits the Metastasis of Colorectal Cancer via Epidermal Growth Factor Receptor Signaling Axis.

Lan Thi Hanh Phi1, Ita Novita Sari1, Yoseph Toni Wijaya1, Kwang Seock Kim1, Kichul Park2, Art E Cho2, Hyog Young Kwon1.   

Abstract

Ginsenoside Rd is a saponin from ginseng and has been reported to have various biological activities. However, the effect of ginsenoside Rd on the metastasis of colorectal cancer (CRC) remains unknown. Here, we found that ginsenoside Rd decreased the colony-forming ability, migration, invasion, and wound-healing abilities of CRC cells, although it did not affect cell proliferation. In addition, using an inverse-docking assay, we found that ginsenoside Rd bound to epidermal growth factor receptor (EGFR) with a high binding affinity, inducing the downregulation of stemness- and epithelial-mesenchymal transition-related genes; these were partially rescued by either exogenous EGF treatment or ectopic expression of SOX2. Furthermore, ginsenoside Rd significantly decreased the number and size of tumor metastasis nodules in the livers, lungs, and kidneys of mouse model of metastasis.
© 2018 IUBMB Life, 71(5):601-610, 2019. © 2018 International Union of Biochemistry and Molecular Biology.

Entities:  

Keywords:  CSCs; EMT; colorectal cancer; ginsenoside Rd

Mesh:

Substances:

Year:  2018        PMID: 30576064     DOI: 10.1002/iub.1984

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  8 in total

Review 1.  Insights into Recent Studies on Biotransformation and Pharmacological Activities of Ginsenoside Rd.

Authors:  Xiaoping Song; Lina Wang; Daidi Fan
Journal:  Biomolecules       Date:  2022-03-28

2.  20(R)-Ginsenoside Rg3 Influences Cancer Stem Cell Properties and the Epithelial-Mesenchymal Transition in Colorectal Cancer via the SNAIL Signaling Axis.

Authors:  Lan Thi Hanh Phi; Yoseph Toni Wijaya; Ita Novita Sari; Kwang Seock Kim; Ying-Gui Yang; Min-Woo Lee; Hyog Young Kwon
Journal:  Onco Targets Ther       Date:  2019-12-11       Impact factor: 4.147

Review 3.  Strategies for Remodeling the Tumor Microenvironment Using Active Ingredients of Ginseng-A Promising Approach for Cancer Therapy.

Authors:  Mo Li; Xin Wang; Ying Wang; Shunchao Bao; Qing Chang; Linlin Liu; Shuai Zhang; Liwei Sun
Journal:  Front Pharmacol       Date:  2021-12-22       Impact factor: 5.810

4.  Ginsenoside Rd Attenuates Tau Phosphorylation in Olfactory Bulb, Spinal Cord, and Telencephalon by Regulating Glycogen Synthase Kinase 3β and Cyclin-Dependent Kinase 5.

Authors:  Ling Li; Tian Li; Xin Tian; Ling Zhao
Journal:  Evid Based Complement Alternat Med       Date:  2021-12-26       Impact factor: 2.629

Review 5.  Traditional Chinese Medicines as Effective Reversals of Epithelial-Mesenchymal Transition Induced-Metastasis of Colorectal Cancer: Molecular Targets and Mechanisms.

Authors:  Hongzhang Ge; Chao Xu; Haitao Chen; Ling Liu; Lei Zhang; Changhong Wu; Yi Lu; Qinghua Yao
Journal:  Front Pharmacol       Date:  2022-03-04       Impact factor: 5.810

Review 6.  Biotransformation, Pharmacokinetics, and Pharmacological Activities of Ginsenoside Rd Against Multiple Diseases.

Authors:  Jing Li; Qingxia Huang; Yao Yao; Peng Ji; E Mingyao; Jinjin Chen; Zepeng Zhang; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Lei Zhou; Xiangyan Li
Journal:  Front Pharmacol       Date:  2022-07-19       Impact factor: 5.988

7.  Ginsenoside Rd inhibits migration and invasion of tongue cancer cells through H19/miR-675-5p/CDH1 axis.

Authors:  Lu Chang; Dongxu Wang; Shaoning Kan; Ming Hao; Huimin Liu; Zhijing Yang; Qianyun Xia; Weiwei Liu
Journal:  J Appl Oral Sci       Date:  2022-09-02       Impact factor: 3.144

8.  Ginsenoside Rd protects cerebral endothelial cells from oxygen-glucose deprivation/reoxygenation induced pyroptosis via inhibiting SLC5A1 mediated sodium influx.

Authors:  Suping Li; Nengwei Yu; Fei Xu; Liang Yu; Qian Yu; Jing Fu
Journal:  J Ginseng Res       Date:  2022-05-21       Impact factor: 5.735

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.